PIERIS PHARMACEUTICALS INC's ticker is PIRS and the CUSIP is 720795103. A total of 96 filers reported holding PIERIS PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $66,000 | -77.6% | 21,600 | -72.3% | 0.01% | -81.4% |
| Q4 2021 | $295,000 | +619.5% | 77,985 | +622.1% | 0.04% | +616.7% |
| Q2 2021 | $41,000 | -43.1% | 10,800 | -46.0% | 0.01% | -60.0% |
| Q4 2019 | $72,000 | -51.0% | 20,000 | -53.7% | 0.02% | -60.5% |
| Q3 2019 | $147,000 | -30.7% | 43,231 | -3.9% | 0.04% | -38.7% |
| Q2 2019 | $212,000 | +40.4% | 45,000 | 0.0% | 0.06% | +40.9% |
| Q1 2019 | $151,000 | +7.1% | 45,000 | -15.3% | 0.04% | +22.2% |
| Q4 2018 | $141,000 | -44.0% | 53,159 | +18.1% | 0.04% | -25.0% |
| Q3 2018 | $252,000 | +10.5% | 45,000 | 0.0% | 0.05% | -56.8% |
| Q2 2018 | $228,000 | +67.6% | 45,000 | +125.0% | 0.11% | +246.9% |
| Q1 2018 | $136,000 | – | 20,000 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lynx1 Capital Management LP | 5,628,585 | $5,853,728 | 5.06% |
| Aquilo Capital Management, LLC | 4,552,876 | $4,734,991 | 1.78% |
| BVF INC/IL | 5,080,320 | $5,283,533 | 0.22% |
| Soleus Capital Management, L.P. | 1,000,000 | $1,040,000 | 0.15% |
| Cutter & CO Brokerage, Inc. | 378,479 | $393,618 | 0.13% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 1,220,798 | $1,269,630 | 0.05% |
| GSA CAPITAL PARTNERS LLP | 365,047 | $380 | 0.05% |
| Annandale Capital, LLC | 67,000 | $70 | 0.02% |
| WEALTH EFFECTS LLC | 21,700 | $22,568 | 0.01% |
| Sigma Planning Corp | 343,934 | $357,691 | 0.01% |